{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:25:13Z","timestamp":1794266713623,"version":"4.9.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.peptides.2024.171200","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:35:55Z","timestamp":1711636555000},"page":"171200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut"],"prefix":"10.1016","volume":"176","author":[{"given":"Nadya M.","family":"Morrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Mulvihill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.peptides.2024.171200_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41574-019-0168-8","article-title":"Function and mechanisms of enteroendocrine cells and gut hormones in metabolism","volume":"15","author":"Gribble","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.peptides.2024.171200_bib2","doi-asserted-by":"crossref","first-page":"R2163","DOI":"10.1152\/ajpregu.00911.2006","article-title":"Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system","volume":"293","author":"D'Alessio","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib3","doi-asserted-by":"crossref","first-page":"G963","DOI":"10.1152\/ajpgi.00146.2007","article-title":"The regulation of the lymphatic secretion of glucagon-like peptide-1 (GLP-1) by intestinal absorption of fat and carbohydrate","volume":"293","author":"Lu","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib4","doi-asserted-by":"crossref","first-page":"G1130","DOI":"10.1152\/ajpgi.00400.2007","article-title":"Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose","volume":"294","author":"Lu","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"10","key":"10.1016\/j.peptides.2024.171200_bib5","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","article-title":"Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line","volume":"84","author":"Drucker","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.peptides.2024.171200_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-5793(87)81430-8","article-title":"Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut","volume":"211","author":"Holst","year":"1987","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.peptides.2024.171200_bib7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.peptides.2024.171200_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00401145","article-title":"Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients","volume":"36","author":"Nauck","year":"1993","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.peptides.2024.171200_bib9","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1210\/endo-123-4-2009","article-title":"Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach","volume":"123","author":"Orskov","year":"1988","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.peptides.2024.171200_bib10","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2337\/db11-0979","article-title":"Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans","volume":"60","author":"Christensen","year":"2011","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.peptides.2024.171200_bib11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2337\/diabetes.53.3.654","article-title":"Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects","volume":"53","author":"Meier","year":"2004","journal-title":"Diabetes"},{"issue":"2-3","key":"10.1016\/j.peptides.2024.171200_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0014-2999(96)00795-9","article-title":"Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor","volume":"318","author":"Knudsen","year":"1996","journal-title":"Eur. J. Pharm."},{"issue":"11","key":"10.1016\/j.peptides.2024.171200_bib13","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","article-title":"Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine","volume":"140","author":"Hansen","year":"1999","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.peptides.2024.171200_bib14","first-page":"952","article-title":"Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo","volume":"80","author":"Deacon","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2024.171200_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101351","article-title":"GLP-1 physiology informs the pharmacotherapy of obesity","volume":"57","author":"Drucker","year":"2022","journal-title":"Mol. Metab."},{"issue":"7","key":"10.1016\/j.peptides.2024.171200_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.peptides.2024.171200_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(19)30423-1","article-title":"The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial","volume":"8","author":"Gerstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"10.1016\/j.peptides.2024.171200_bib18","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/STROKEAHA.121.037775","article-title":"Effects of semaglutide on stroke subtypes in type 2 diabetes: post hoc analysis of the randomized SUSTAIN 6 and PIONEER 6","volume":"53","author":"Strain","year":"2022","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.peptides.2024.171200_bib19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0\u2009mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","article-title":"Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus","volume":"91","author":"Nauck","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.peptides.2024.171200_bib22","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2337\/db08-0958","article-title":"Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes","volume":"58","author":"Chia","year":"2009","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.peptides.2024.171200_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ng.521","article-title":"Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge","volume":"42","author":"Saxena","year":"2010","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.peptides.2024.171200_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.686","article-title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index","volume":"42","author":"Speliotes","year":"2010","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.peptides.2024.171200_bib25","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.peptides.2024.171200_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101139","article-title":"Targeting the GIPR for obesity: to agonize or antagonize? Potential mechanisms","volume":"46","author":"Campbell","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2024.171200_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101090","article-title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","volume":"46","author":"Baggio","year":"2021","journal-title":"Mol. Metab."},{"issue":"10160","key":"10.1016\/j.peptides.2024.171200_bib28","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/endrev\/bnac018","article-title":"Glucagon-like peptide-1 receptor-based therapeutics for metabolic liver disease","volume":"44","author":"Yabut","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.peptides.2024.171200_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.peptides.2024.171200_bib31","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson's disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"10103","key":"10.1016\/j.peptides.2024.171200_bib32","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.peptides.2024.171200_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/alzrt174","article-title":"Neuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP\/PS1 mouse model","volume":"5","author":"Faivre","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.peptides.2024.171200_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuroscience.2012.10.045","article-title":"The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP\/PS1 mouse model of Alzheimer's disease","volume":"228","author":"Duffy","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2024.171200_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2015.10.002","article-title":"Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model","volume":"101","author":"Li","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.peptides.2024.171200_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2016.11.050","article-title":"D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation","volume":"797","author":"Li","year":"2017","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.peptides.2024.171200_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2017.06.029","article-title":"A novel GLP-1\/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease","volume":"812","author":"Yuan","year":"2017","journal-title":"Eur. J. Pharm."},{"issue":"7","key":"10.1016\/j.peptides.2024.171200_bib38","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/eurheartj\/ehz728","article-title":"Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction","volume":"41","author":"Kahles","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.peptides.2024.171200_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molmet.2018.05.014","article-title":"The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE(-\/-) mice by blocking monocyte\/macrophage activation","volume":"14","author":"Kahles","year":"2018","journal-title":"Mol. Metab."},{"issue":"13","key":"10.1016\/j.peptides.2024.171200_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019477","article-title":"Association of glucose-dependent insulinotropic polypeptide levels with cardiovascular mortality in patients with acute myocardial infarction","volume":"10","author":"Kahles","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jamcollsurg.2019.04.014","article-title":"Persistently elevated glucagon-like peptide-1 levels among critically ill surgical patients after sepsis and development of chronic critical illness and dismal long-term outcomes","volume":"229","author":"Brakenridge","year":"2019","journal-title":"J. Am. Coll. Surg."},{"issue":"7","key":"10.1016\/j.peptides.2024.171200_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.amjmed.2017.03.010","article-title":"GLP-1 levels predict mortality in patients with critical illness as well as end-stage renal disease","volume":"130","author":"Lebherz","year":"2017","journal-title":"Am. J. Med."},{"issue":"10","key":"10.1016\/j.peptides.2024.171200_bib43","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2337\/db14-0100","article-title":"GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering","volume":"63","author":"Kahles","year":"2014","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.peptides.2024.171200_bib44","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells","volume":"17","author":"Ellingsgaard","year":"2011","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.peptides.2024.171200_bib45","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/dom.12711","article-title":"Glucose-dependent insulinotropic peptide secretion is induced by inflammatory stimuli in an interleukin-1-dependent manner in mice","volume":"18","author":"Kahles","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"10.1016\/j.peptides.2024.171200_bib46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/1056-8719(95)00001-X","article-title":"Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid","volume":"33","author":"Wallace","year":"1995","journal-title":"J. Pharm. Toxicol. Methods"},{"issue":"4","key":"10.1016\/j.peptides.2024.171200_bib47","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.5114\/aoms.2019.86704","article-title":"Effects of experimental colitis in rats on incretin levels, inflammatory markers, and enteric neuronal function","volume":"17","author":"Derosa","year":"2021","journal-title":"Arch. Med. Sci."},{"issue":"17","key":"10.1016\/j.peptides.2024.171200_bib48","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.4254\/wjh.v7.i17.2058","article-title":"Intestinal barrier dysfunction in cirrhosis: current concepts in pathophysiology and clinical implications","volume":"7","author":"Tsiaoussis","year":"2015","journal-title":"World J. Hepatol."},{"issue":"10","key":"10.1016\/j.peptides.2024.171200_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.54","article-title":"Human intestinal barrier function in health and disease","volume":"7","author":"Konig","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2304157","article-title":"Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus","volume":"16","author":"Forlano","year":"2024","journal-title":"Gut Microbes"},{"issue":"7","key":"10.1016\/j.peptides.2024.171200_bib51","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2337\/db14-1577","article-title":"GLP-1R Agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R","volume":"64","author":"Yusta","year":"2015","journal-title":"Diabetes"},{"issue":"6502","key":"10.1016\/j.peptides.2024.171200_bib52","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/372190a0","article-title":"Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin","volume":"372","author":"Cepek","year":"1994","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.peptides.2024.171200_bib53","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri3007","article-title":"The light and dark sides of intestinal intraepithelial lymphocytes","volume":"11","author":"Cheroutre","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.peptides.2024.171200_bib54","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.it.2017.11.003","article-title":"Intestinal intraepithelial lymphocytes: sentinels of the mucosal barrier","volume":"39","author":"Olivares-Villagomez","year":"2018","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib55","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/eji.1830200523","article-title":"Subsets of CD3+ (T cell receptor alpha\/beta or gamma\/delta) and CD3- lymphocytes isolated from normal human gut epithelium display phenotypical features different from their counterparts in peripheral blood","volume":"20","author":"Jarry","year":"1990","journal-title":"Eur. J. Immunol."},{"issue":"7742","key":"10.1016\/j.peptides.2024.171200_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-018-0849-9","article-title":"Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease","volume":"566","author":"He","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.peptides.2024.171200_bib57","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cmet.2022.08.003","article-title":"Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation","volume":"34","author":"Wong","year":"2022","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.peptides.2024.171200_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081887","article-title":"Tumour necrosis factor alpha in intestinal homeostasis and gut related diseases","volume":"20","author":"Ruder","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.peptides.2024.171200_bib59","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1073\/pnas.1112519109","article-title":"Dynamic migration of gammadelta intraepithelial lymphocytes requires occludin","volume":"109","author":"Edelblum","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.peptides.2024.171200_bib60","doi-asserted-by":"crossref","first-page":"15 25 1","DOI":"10.1002\/0471142735.im1525s104","article-title":"Dextran sulfate sodium (DSS)-induced colitis in mice","volume":"104","author":"Chassaing","year":"2014","journal-title":"Curr. Protoc. Immunol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib61","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1053\/gast.2002.32991","article-title":"The role of transforming growth factor beta-2, beta-3 in mediating apoptosis in the murine intestinal mucosa","volume":"122","author":"Dunker","year":"2002","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.peptides.2024.171200_bib62","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2012-303280","article-title":"Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis","volume":"62","author":"Kissow","year":"2013","journal-title":"Gut"},{"issue":"1-3","key":"10.1016\/j.peptides.2024.171200_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.regpep.2012.08.016","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice","volume":"179","author":"Kissow","year":"2012","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.peptides.2024.171200_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib65","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050793","article-title":"Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib67","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib68","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.celrep.2017.10.008","article-title":"Enteroendocrine L cells sense LPS after gut barrier injury to enhance GLP-1 secretion","volume":"21","author":"Lebrun","year":"2017","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.peptides.2024.171200_bib69","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.celrep.2014.10.032","article-title":"Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells","volume":"9","author":"Chimerel","year":"2014","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.peptides.2024.171200_bib70","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1096\/fj.14-265983","article-title":"Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity","volume":"29","author":"Hwang","year":"2015","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.peptides.2024.171200_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109163","article-title":"The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism","volume":"35","author":"Heiss","year":"2021","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib72","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.chom.2013.09.012","article-title":"Microbial modulation of energy availability in the colon regulates intestinal transit","volume":"14","author":"Wichmann","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"35","key":"10.1016\/j.peptides.2024.171200_bib73","doi-asserted-by":"crossref","first-page":"25088","DOI":"10.1074\/jbc.M113.452516","article-title":"Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion","volume":"288","author":"Yadav","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.9","article-title":"Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects","volume":"1","author":"Wang","year":"2018","journal-title":"Endocrinol. Diabetes Metab."},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib75","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1038\/s41598-021-88612-x","article-title":"Effects of GLP-1 receptor agonist on changes in the gut bacterium and the underlying mechanisms","volume":"11","author":"Kato","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52103-x","article-title":"Metabolic and gut microbiome changes following GLP-1 or dual GLP-1\/GLP-2 receptor agonist treatment in diet-induced obese mice","volume":"9","author":"Madsen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2024.171200_bib77","doi-asserted-by":"crossref","first-page":"101924","DOI":"10.1016\/j.molmet.2024.101924","article-title":"GLP-1R signaling modulates colonic energy metabolism, goblet cell number and survival in the absence of gut microbiota","author":"Greiner","year":"2024","journal-title":"Molecular Metabolism"},{"issue":"7","key":"10.1016\/j.peptides.2024.171200_bib78","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","article-title":"Best practices for analysing microbiomes","volume":"16","author":"Knight","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.peptides.2024.171200_bib79","article-title":"Role of metabolic endotoxemia in systemic inflammation and potential interventions","volume":"11","author":"Mohammad","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.peptides.2024.171200_bib80","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1210\/en.2015-1361","article-title":"Chronic exposure to TNFalpha impairs secretion of glucagon-like peptide-1","volume":"156","author":"Gagnon","year":"2015","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"issue":"6589","key":"10.1016\/j.peptides.2024.171200_bib82","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/382366a0","article-title":"Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue","volume":"382","author":"Wagner","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2024.171200_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.678055","article-title":"The interplay of glucagon-like peptide-1 receptor trafficking and signalling in pancreatic beta cells","volume":"12","author":"Marzook","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib84","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.cmet.2017.04.013","article-title":"A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric NO-dependent and gut-brain axis mechanism","volume":"25","author":"Grasset","year":"2017","journal-title":"Cell Metab."},{"issue":"16","key":"10.1016\/j.peptides.2024.171200_bib85","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140418","article-title":"Hematopoietic cell- versus enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice","volume":"5","author":"Varin","year":"2020","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.peptides.2024.171200_bib86","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.peptides.2024.171200_bib87","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.4049\/jimmunol.1601441","article-title":"Glucose-dependent insulinotropic polypeptide receptor deficiency leads to impaired bone marrow hematopoiesis","volume":"198","author":"Mantelmacher","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.peptides.2024.171200_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101008","article-title":"The gut hormone receptor GIPR links energy availability to the control of hematopoiesis","volume":"39","author":"Pujadas","year":"2020","journal-title":"Mol. Metab."},{"issue":"2","key":"10.1016\/j.peptides.2024.171200_bib89","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1440-1746.2009.05997.x","article-title":"Eukaryotic expression of extracellular ligand binding domains of murine Tie-2 and its anti-angiogenesis effect in SGC-7901 cell lines","volume":"25","author":"Yang","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5411","key":"10.1016\/j.peptides.2024.171200_bib90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.peptides.2024.171200_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413422","article-title":"Molecular morphology and function of stromal cells","volume":"22","author":"Manetti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.peptides.2024.171200_bib92","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mucimm.2023.01.006","article-title":"Stromal regulation of the intestinal barrier","volume":"16","author":"Sylvestre","year":"2023","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.peptides.2024.171200_bib93","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/cbir.1996.0018","article-title":"Epithelial cell migration in the intestine","volume":"20","author":"Heath","year":"1996","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02889852","article-title":"The effects of starvation and refeeding on intestinal cell proliferation in the mouse","volume":"45","author":"Goodlad","year":"1984","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"issue":"4","key":"10.1016\/j.peptides.2024.171200_bib95","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/aja.1001680405","article-title":"Chronobiology of the intestinal tract of the mouse","volume":"168","author":"Scheving","year":"1983","journal-title":"Am. J. Anat."},{"issue":"4","key":"10.1016\/j.peptides.2024.171200_bib96","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0016-5085(94)90757-9","article-title":"Circadian variations of epithelial cell proliferation in human rectal crypts","volume":"106","author":"Marra","year":"1994","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.peptides.2024.171200_bib97","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0016-5085(91)90019-H","article-title":"Circadian rhythm of cellular proliferation in the human rectal mucosa","volume":"101","author":"Buchi","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.peptides.2024.171200_bib98","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/ncomms2668","article-title":"Microbiota-derived lactate accelerates colon epithelial cell turnover in starvation-refed mice","volume":"4","author":"Okada","year":"2013","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib99","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0002-9610(02)01146-7","article-title":"Effect of route and type of nutrition on intestine-derived inflammatory responses","volume":"185","author":"Kudsk","year":"2003","journal-title":"Am. J. Surg."},{"issue":"5","key":"10.1016\/j.peptides.2024.171200_bib100","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2019.07.047","article-title":"Fasting-refeeding impacts immune cell dynamics and mucosal immune responses","volume":"178","author":"Nagai","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2024.171200_bib101","article-title":"GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion","author":"Gandasi","year":"2023","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.peptides.2024.171200_bib102","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cmet.2016.10.007","article-title":"Cellular sites and mechanisms linking reduction of dipeptidyl peptidase-4 activity to control of incretin hormone action and glucose homeostasis","volume":"25","author":"Mulvihill","year":"2017","journal-title":"Cell Metab."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T18:03:55Z","timestamp":1714241035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978124000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":102,"alternative-id":["S0196978124000536"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171200","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"171200"}}